NCT03628495

Brief Summary

Pressure therapy (PT) and silicone therapy are recommended as first-line non-invasive treatments HS, yet the effectiveness of the combination of these two treatments through an RCT trial has not been established yet. This study aims to examine the effectiveness of the combination of adequate pressure therapy and silicone gel sheeting implemented by Smart Scar Care Pad (SSCP) + Smart Pressure Monitored Suit (SPMS) versus conventional Pressure Garment (PG in the management of severe HS in adult. It is hypothesized that the combination of adequate pressure therapy and silicone gel sheeting will demonstrate its superiority in improving scar parameters than conventional pressure garment therapy.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
72

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2018

Typical duration for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 23, 2018

Completed
3 months until next milestone

First Posted

Study publicly available on registry

August 14, 2018

Completed
18 days until next milestone

Study Start

First participant enrolled

September 1, 2018

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2020

Completed
Last Updated

August 14, 2018

Status Verified

August 1, 2018

Enrollment Period

1.8 years

First QC Date

May 23, 2018

Last Update Submit

August 9, 2018

Conditions

Keywords

insertpressure therapysilicone gel

Outcome Measures

Primary Outcomes (1)

  • Change from baseline HS thickness at 6 months

    HS thickness measured by the Diagnostic Ultrasound System

    at baseline, one and six month after treatment

Secondary Outcomes (5)

  • Change from baseline HS color at 6 months

    at baseline, one and six month after treatment

  • Change from baseline HS pliability at 6 months

    at baseline, one and six month after treatment

  • Change from baseline HS hydration at 6 months

    at baseline, one and six month after treatment

  • Itchiness

    at baseline, one and six month after treatment

  • QoL

    at baseline, one and six month after treatment

Study Arms (2)

SSCP + SPMS

EXPERIMENTAL
Device: compressionDevice: occlusion

PG

ACTIVE COMPARATOR
Device: compression

Interventions

compression will be delivered using compression garment

PGSSCP + SPMS
occlusionDEVICE

occlusion will be delivered using silicone gel sheeting

SSCP + SPMS

Eligibility Criteria

Age20 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • The Vancouver Scar Scale (VSS) will be used to screen candidates for the study.10 Isolated scars with a total score of 4 or higher and the score of each item equal to or greater than 1 will be included.
  • The scar size should also reach 2\*2 cm2 or above to allow adequate area for assessment tool attachement.
  • Consenting adult's age between 19 to 60 years old who is able to provide written consent, cooperative, and good compliance with treatment.

You may not qualify if:

  • the HS area have an open wound or infection;
  • the HS have been treated with steroid injections or other intervention (such as traditional Chinese medicine or laser therapy) prior to the study;
  • the patients have a medical condition that might affect wound healing (e.g., diabetes mellitus or another serious medical problem);
  • the patients with comorbidities that might affect their compliance to treatment: such as severe scar contracture at adjacent area that might be scheduled for reconstructive surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Cicatrix, Hypertrophic

Interventions

Dental Occlusion

Condition Hierarchy (Ancestors)

CicatrixFibrosisPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

DentistryDental Physiological PhenomenaDigestive System and Oral Physiological Phenomena

Study Officials

  • Cecilia Li, PhD

    The Hong Kong Polytechnic University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
The ultrasound data will be processed and the data will be analysed by analysts who are blinded.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 23, 2018

First Posted

August 14, 2018

Study Start

September 1, 2018

Primary Completion

July 1, 2020

Study Completion

July 1, 2020

Last Updated

August 14, 2018

Record last verified: 2018-08

Data Sharing

IPD Sharing
Will not share